Rigaku Corporation, a Group company of Rigaku Holdings Corporation, and SPERA PHARMA, Inc. have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive expertise. SPERA PHARMA will use XtaLAB Synergy-E…
Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic cooperation agreement with Polpharma Biologics to advance the end-to-end development and manufacture of a biosimilar product for the global market. This partnership underscores Chime Biologics' co…
Illumina Inc. a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. The collaboration will combine leading Illumina AI technologies with Tempus's co…
Lonza, a global development and manufacturing partner to the pharmaceutical and biotech markets, announced it has joined CMAC, a world leading centre for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture. Based at the University o…
Thermo Fisher Scientific Inc, the world leader in serving science, has signed a strategic Memorandum of Understanding with NSG BIO, Singapore's largest BSL-2-certified, co-working laboratory and office space. This collaboration aims to empower biotech startups in Singapore with access to critical resources, advanced l…
AGC Biologics announced a strategic decision about the large-scale single-use technology it will use at its new Yokohama, Japan facility. The CDMO is introducing two 5,000 L Thermo Scientific DynaDrive Single-Use Bioreactors (S.U.B.), which makes the site one of the most advanced in Japan for large-scale mammalian-ba…
Veltris, a digital product engineering services provider backed by Trive Capital and BayLink Capital is pleased to announce the acquisition of BPK Technologies . This acquisition advances Veltris' strategic direction towards industry solutions and expands its digital engineering and data/AI capabilities to help client…
LOTTE BIOLOGICS signed a Memorandum of Understanding (MOU) with Asimov, a company headquartered in Boston, Massachusetts, to collaborate in the Contract Development and Manufacturing Organization (CDMO) business. Through this agreement, LOTTE BIOLOGICS plans to leverage Asimov’s next-generation cell line development p…
BIOQuébec and Life Sciences Ontario (LSO), two leading life sciences associations, are proud to announce the signing of a Memorandum of Understanding (MOU) to enhance collaboration and foster growth across Québec and Ontario. In today’s economic climate, strengthening interprovincial partnerships is crucial to driving…
Azurity Pharmaceuticals announced the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This strategic acquisition reinforces Azurity's leadership in branded pharmaceuticals, harnessing the…
Page 34 of 36